• 1. Department of Liver Surgery and Organ Transplantation Center, Shenzhen Third People’s Hospital, Shenzhen, Guangdong 518112, P. R. China;
  • 2. National Clinical Research Center for Infectious Disease, Shenzhen, Guangdong 518112, P. R. China;
  • 3. School of Medcine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, P. R. China;
  • 4. School of Environment, Southern University of Science and Technology, Shenzhen, Guangdong 518055, P. R. China;
  • 5. Department of Liver Transplantation, Organ Transplantation Center, Tianjin First Central Hospital, Tianjin 300190, P. R. China;
  • 6. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China;
  • 7. Department of General Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, P. R. China;
  • 8. Department of Organ Transplantation, You’an Hospital, Capital Medical University, Beijing 100069, P. R. China;
  • 9. Organ Transplant Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 10. Organ Transplant Center of Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P. R. China;
  • 11. Organ Transplant Center of The First Hospital of Jilin University, Changchun 130031, P. R. China;
  • 12. Organ Transplant Center of The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China;
  • 13. Organ Transplant Center of Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan 430014, P. R. China;
YANG Jiayin, Email: doctoryjy@scu.edu.cn; ZHONG Lin, Email: zhonglin1@medmail.com.cn
Export PDF Favorites Scan Get Citation

Organ transplantation is a critical treatment for end-stage organ diseases, yet postoperative infections significantly affect patient outcomes. Traditional diagnostic methods for infections often fall short in meeting the demands of precise prevention and treatment due to limitations in sensitivity, specificity, and speed. Targeted nanopore pathogen sequencing technology, characterized by its long-read capability, real-time detection, and adaptability, has shown unique potential in pathogen identification, structural variation analysis, and antimicrobial resistance gene profiling. This offers new insights into the prevention and management of postoperative infections. This expert consensus focuses on the standardized application of this technology in managing infections following organ transplantation, addressing its principles, clinical recommendations, and diagnostic workflows. By exploring its features and value in infectious disease diagnosis, the expert consensus provides standardized guidance on sample processing and result interpretation. The development of this consensus aims to promote the rational use of nanopore sequencing in diagnosing and treating post-transplant infections, enhance diagnostic accuracy and efficiency, improve patient outcomes, and facilitate the widespread adoption of this technology.

Citation: HUANG Yiming, SUN Yunke, WANG Pusen, ZHAO Dong, QUE Weitao, FANG Taishi, CHEN Qijun, YANG Liang, XIA Yu, GAO Wei, GUO Wenzhi, FU Zhiren, LI Guangming, KONG Lingxiang, WANG Shouping, CAI Jinzhen, LÜ Guoyue, WU Zhongjun, CHEN Gang, YANG Jiayin, ZHONG Lin. Multicenter expert consensus on application of targeted nanopore pathogen sequencing technology in prevention and treatment of infections in organ transplantation. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2025, 32(1): 15-21. doi: 10.7507/1007-9424.202501067 Copy

Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved

  • Previous Article

    Interpretation of 2024 ESC guidelines for the management of peripheral arterial and aortic diseases
  • Next Article

    Risk and prevention strategies for donor-derived infections in liver transplantation